Details

Title
Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency
Author
Jørgensen, S. F. 1 ; Macpherson, M. E. 1 ; Bjørnetrø, T. 2 ; Holm, K. 3 ; Kummen, M. 2 ; Rashidi, A. 4 ; Michelsen, A. E. 5 ; Lekva, T. 4   VIAFID ORCID Logo  ; Halvorsen, B. 5 ; Trøseid, M. 1 ; Mollnes, T. E. 6 ; Berge, R. K. 7 ; Yndestad, A. 5 ; Ueland, T. 5 ; Karlsen, T. H. 3 ; Aukrust, P. 1 ; Hov, J. R. 3   VIAFID ORCID Logo  ; Fevang, B. 8 

 Oslo University Hospital, Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Rikshospitalet, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485); Oslo University Hospital, Section of Clinical Immunology and Infectious Diseases, Department of Rheumatology, Dermatology and Infectious Diseases, Rikshospitalet, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485); University of Oslo, Institute of Clinical Medicine, Oslo, Norway (GRID:grid.5510.1) (ISNI:0000 0004 1936 8921) 
 Oslo University Hospital, Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Rikshospitalet, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485); Oslo University Hospital Rikshospitalet, Norwegian PSC Research Center, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485) 
 Oslo University Hospital, Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Rikshospitalet, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485); University of Oslo, Institute of Clinical Medicine, Oslo, Norway (GRID:grid.5510.1) (ISNI:0000 0004 1936 8921); Oslo University Hospital Rikshospitalet, Norwegian PSC Research Center, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485) 
 Oslo University Hospital, Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Rikshospitalet, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485) 
 Oslo University Hospital, Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Rikshospitalet, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485); University of Oslo, Institute of Clinical Medicine, Oslo, Norway (GRID:grid.5510.1) (ISNI:0000 0004 1936 8921) 
 University of Tromsø, Research Laboratory, Nordland Hospital, Bodø, and Faculty of Health Sciences, K.G. Jebsen TREC, Tromsø, Norway (GRID:grid.416371.6) (ISNI:0000 0001 0558 0946); Norwegian University of Science and Technology, Centre of Molecular Inflammation Research, Trondheim, Norway (GRID:grid.5947.f) (ISNI:0000 0001 1516 2393); Oslo University Hospital, and University of Oslo, Department of Immunology, Oslo, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485) 
 University of Bergen, Department of Clinical Science, Bergen, Norway (GRID:grid.7914.b) (ISNI:0000 0004 1936 7443); Haukeland University Hospital, Department of Heart Disease, Bergen, Norway (GRID:grid.412008.f) (ISNI:0000 0000 9753 1393) 
 Oslo University Hospital, Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Rikshospitalet, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485); Oslo University Hospital, Section of Clinical Immunology and Infectious Diseases, Department of Rheumatology, Dermatology and Infectious Diseases, Rikshospitalet, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485) 
Pages
3704
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2926326968
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.